Associated Papers
Association Lp-PLA2 Gene Polymorphisms with Coronary Heart Disease.
Ma S et al.
Disease Markers, 2022
Interaction between nonsynonymous polymorphisms in PLA2G7 gene and smoking on the risk of coronary heart disease in a Chinese population.
Chi Y et al.
Journal of Thrombosis and Thrombolysis, 2018
Correlations Between LP-PLA2 Gene Polymorphisms and Susceptibility and Severity of Acute Pancreatitis in a Chinese Population.
Ma M et al.
Genetic Testing and Molecular Biomarkers, 2017
Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles.
Gregson JM et al.
European Journal of Preventive Cardiology, 2017
A previously unreported impact of a PLA2G7 gene polymorphism on the plasma levels of lipoprotein-associated phospholipase A2 activity and mass.
Qi Y et al.
Scientific Reports, 2016
Associations of platelet-activating factor acetylhydrolase gene polymorphisms with risk of ischemic stroke.
Ma Y
Biomedical Reports, 2016
Nonsynonymous polymorphisms in PLA2G7 gene are associated with the risk of coronary heart disease in a southern Chinese population.
Hong M et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society, 2015
Effects of A379V variant of the Lp-PLA 2 gene on Lp-PLA 2 activity and markers of oxidative stress and endothelial function in Koreans.
Chae JS et al.
Journal of Thrombosis and Thrombolysis, 2014
Associations of platelet-activating factor acetylhydrolase (PAF-AH) gene polymorphisms with circulating PAF-AH levels and risk of coronary heart disease or blood stasis syndrome in the Chinese Han population.
Zheng GH et al.
Molecular Biology Reports, 2014
Association of PLA2G7 gene polymorphisms with ischemic stroke in northern Chinese Han population.
Liu X et al.
Clinical Biochemistry, 2014
Sequencing of Lp-PLA2-encoding PLA2G7 gene in 2000 Europeans reveals several rare loss-of-function mutations.
Song K et al.
The Pharmacogenomics Journal, 2012
Lipoprotein-associated phospholipase A2 gene V279F polymorphisms and coronary heart disease: a meta-analysis.
Zheng GH et al.
Molecular Biology Reports, 2011
PLA2G7 gene polymorphisms and coronary heart disease risk: a meta-analysis.
Wang Q et al.
Thrombosis Research, 2010
Study of association between genetic polymorphisms of phospholipase A2 enzymes and Alzheimer's disease.
Cordeiro Q et al.
Arquivos De Neuro-psiquiatria, 2010
Association of PLA2G7 polymorphisms with carotid atherosclerosis in hypertensive Japanese.
Miwa Y et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension, 2009
Genetic variants and haplotypes of lipoprotein associated phospholipase A2 and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study).
Hoffmann MM et al.
Journal of Thrombosis and Haemostasis : Jth, 2009
The Val279Phe variant of the lipoprotein-associated phospholipase A2 gene is associated with catalytic activities and cardiovascular disease in Korean men.
Jang Y et al.
The Journal of Clinical Endocrinology and Metabolism, 2006
Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction.
Liu PY et al.
Journal of Thrombosis and Haemostasis : Jth, 2006
Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma.
Satoh N et al.
American Journal of Respiratory and Critical Care Medicine, 1999